Tiziana Life Sciences CEO Buys Shares
Ticker: TLSA · Form: 6-K · Filed: Sep 9, 2025 · CIK: 1723069
| Field | Detail |
|---|---|
| Company | Tiziana Life Sciences Ltd (TLSA) |
| Form Type | 6-K |
| Filed Date | Sep 9, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $1.65 |
| Sentiment | bullish |
Sentiment: bullish
Topics: insider-buy, ceo-purchase, biotech
TL;DR
CEO Elrifi just bought 193,848 Tiziana shares at $1.65 - bullish signal?
AI Summary
On September 9, 2025, Tiziana Life Sciences LTD announced that its CEO, Ivor Elrifi, purchased 193,848 shares of the company's common stock in the open market. The shares were acquired at a price of $1.65 per share.
Why It Matters
Insider buying can signal confidence from leadership in the company's future prospects.
Risk Assessment
Risk Level: medium — Insider buying is generally positive, but the overall financial health and market performance of Tiziana Life Sciences will determine the true risk.
Key Numbers
- 193,848 — Shares Purchased (Number of shares bought by CEO Ivor Elrifi)
- $1.65 — Price Per Share (Price at which CEO Ivor Elrifi purchased shares)
Key Players & Entities
- Tiziana Life Sciences LTD (company) — Company filing the report
- Ivor Elrifi (person) — CEO of Tiziana Life Sciences
- 193,848 shares (dollar_amount) — Number of shares purchased by CEO
- $1.65 (dollar_amount) — Price per share paid by CEO
- September 9, 2025 (date) — Date of the transaction announcement
FAQ
What is the total dollar amount of the CEO's stock purchase?
The CEO, Ivor Elrifi, purchased 193,848 shares at $1.65 per share, totaling approximately $319,849.20.
When did this stock purchase occur?
The announcement of the purchase was made on September 9, 2025, and the purchase was made in the open market.
What is the filing type and its purpose?
This is a Form 6-K, which is a Report of Foreign Private Issuer, used to announce significant events or information to the SEC.
What is Tiziana Life Sciences' primary business?
Tiziana Life Sciences is in the Pharmaceutical Preparations industry (SIC code 2834).
Where is Tiziana Life Sciences headquartered?
Tiziana Life Sciences LTD is headquartered in London, England.
Filing Stats: 312 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2025-09-09 08:30:02
Key Financial Figures
- $1.65 — s of Tiziana common stock at a price of $1.65 per share in the open market. The Anno
Filing Documents
- ea0256587-6k_tiziana.htm (6-K) — 14KB
- ea025658701ex99-1_tiziana.htm (EX-99.1) — 6KB
- ex99-1_001.jpg (GRAPHIC) — 6KB
- 0001213900-25-085865.txt ( ) — 29KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TIZIANA LIFE SCIENCES LTD Date: September 9, 2025 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 2 EXHIBIT INDEX Exhibit No. Description 99.1 Tiziana Life Sciences LTD Press Release, dated September 9, 2025 3